CDH2 and gastric cancer: In general, it was found that Luteolin exerted its biological properties by inhibiting Cyclin D1, Cyclin E, Bcl2, MMP-2, MMP-9, N-cadherin, Vimentin, and inducing p21, Bax, and E-Cadherin expressions in gastric cancer cells.